Single Ascending Dose of FXI-GalNAc-siRNA in Healthy Subjects

NCT05844293 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
40
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sirnaomics